Advagene Biopharma Co., Ltd. (TPEX:6709)
25.90
+0.35 (1.37%)
May 29, 2026, 1:35 PM CST
52.35% (1Y)
| Market Cap | 1.53B +50.4% |
| Revenue (ttm) | n/a |
| Net Income | -68.29M |
| EPS | -1.15 |
| Shares Out | 59.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 19,000 |
| Open | 25.70 |
| Previous Close | 25.55 |
| Day's Range | 25.70 - 26.00 |
| 52-Week Range | 16.80 - 41.00 |
| Beta | 0.68 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |